Roundview Capital’s T. Rowe Price Blue Chip Growth ETF TCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
36,588
+119
+0.3% +$5.63K 0.1% 174
2025
Q4
$1.82M Buy
36,469
+4,903
+16% +$243K 0.11% 164
2025
Q3
$1.54M Buy
31,566
+2,826
+10% +$133K 0.1% 179
2025
Q2
$1.3M Buy
28,740
+12,604
+78% +$512K 0.09% 187
2025
Q1
$615K Buy
16,136
+2,785
+21% +$116K 0.04% 241
2024
Q4
$562K Buy
13,351
+1,553
+13% +$64.5K 0.04% 259
2024
Q3
$468K Buy
11,798
+1,188
+11% +$45.5K 0.03% 278
2024
Q2
$411K Buy
10,610
+21
+0.2% +$758 0.03% 271
2024
Q1
$374K Buy
10,589
+648
+7% +$21.7K 0.03% 276
2023
Q4
$308K Buy
9,941
+2,332
+31% +$67.6K 0.03% 276
2023
Q3
$207K Buy
7,609
+25
+0.3% +$701 0.02% 300
2023
Q2
$211K Buy
+7,584
New +$194K 0.02% 300

Other funds holding TCHP

Roundview Capital's TCHP Position: Q1 2026 in Review

Roundview Capital increased its T. Rowe Price Blue Chip Growth ETF (TCHP) stake by 0.33% in Q1 2026, buying an estimated $5.63K and bringing the position to 36,588 shares worth $1.62M. The position accounts for 0.1% of the portfolio, ranked #174.

Roundview Capital first reported a position in TCHP in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.82M in Q4 2025. 176 funds tracked by Wall St. Rank hold TCHP as of Q1 2026.

  • Roundview Capital held 36,588 shares of T. Rowe Price Blue Chip Growth ETF worth $1.62M as of Q1 2026.
  • Roundview Capital bought 119 T. Rowe Price Blue Chip Growth ETF shares in Q1 2026, an estimated $5.63K.
  • T. Rowe Price Blue Chip Growth ETF made up 0.1% of Roundview Capital's portfolio in Q1 2026, its #174 holding.
  • Roundview Capital first reported a position in T. Rowe Price Blue Chip Growth ETF in Q2 2023 and has held it in 12 quarters since.
  • Roundview Capital's T. Rowe Price Blue Chip Growth ETF position peaked at $1.82M in Q4 2025.
  • 176 funds tracked by Wall St. Rank held T. Rowe Price Blue Chip Growth ETF as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.